KKR Eyes Massive Stake in Medicover Hospitals India Amid Global Healthcare Rally; $1B+ Deal Under Discussion

KKR Eyes Massive Stake in Medicover Hospitals India Amid Global Healthcare Rally; $1B+ Deal Under Discussion​

Private equity behemoth KKR is actively in discussions to acquire a substantial stake in Medicover Hospitals India, positioning itself for what could become one of the largest healthcare transactions in the Indian market. This potential deal underscores the intense global investor interest focused on India’s rapidly expanding hospital sector.

Medicover AB, the Swedish-based parent company, has confirmed that it was approached by KKR and is currently exploring a potential sale of its Indian operations. The negotiations include not only the controlling stake but also discussions with minority shareholders, suggesting a comprehensive transaction structure.

Details of the Potential Acquisition Deal​

KKR is seeking to acquire the Swedish firm's entire 66.9 percent stake in Medicover Hospitals India for an amount estimated at at least $1.05 billion. The talks extend beyond a simple buyout and cover a complete transfer of interests, making it a significant move in the healthcare investment landscape.

The opportunity aligns with growing market trends driven by rising domestic healthcare spending, improving insurance penetration, and increasing demand for advanced tertiary care services across India.

Medicover Hospitals: Scale and Operations​

Medicover Hospitals has rapidly built a considerable footprint throughout southern and western parts of India. The operations span four key states: Telangana, Andhra Pradesh, Maharashtra, and Karnataka.

The chain currently operates 25 hospitals, boasting approximately 6,000 beds. These facilities treat nearly two lakh patients each month, establishing Medicover Hospitals as the eighth-largest hospital chain in the country.

Growth Trajectory Amid Buyout Talks​

Despite the high-stakes buyout discussions from KKR, Medicover remains firmly focused on its ongoing public market aspirations. The company’s executive director, P Hari Krishna, confirmed that they are actively working toward an Initial Public Offering (IPO).

Medicover Hospitals generated approximately Rs 1,800 crore in revenue during FY25 and is reporting faster growth compared to the broader industry average. The firm is also near finalizing its financial statements for FY26.

Strategic Focus on IPO Plans​

The company plans to file its draft red herring prospectus (DRHP) either in August or September. This continued focus highlights Medicover’s long-term confidence and commitment to maximizing value for its shareholders.

For the organization, a successful sale outcome would represent one viable exit route, though the option of an IPO remains firmly on the table. This parallel pursuit suggests a strategic effort to achieve maximum shareholder value during a period of strong demand for quality healthcare assets.

Global Private Equity Interest in Indian Healthcare​

The interest shown by KKR is part of a larger trend where private equity firms are actively targeting hospital assets in India. KKR previously exited Max Healthcare and currently holds an investment in HCG, a specialty cancer hospital chain based in Bengaluru.

For the PE firm, acquiring exposure to the fast-growing Indian healthcare sector strengthens its market penetration. The overall expectation across the industry is for sustained growth in patient volumes and rising healthcare expenditures throughout the coming years.